Product
STN1012600
Aliases
STN1012600 ophthalmic solution 0.002%
3 clinical trials
4 indications
Indication
GlaucomaIndication
ocular hypertensionIndication
Primary Open Angle GlaucomaIndication
Healthy Adult Males VolunteersClinical trial
An Open-Label, Long-Term Phase III Study of STN1012600 Ophthalmic Solution Alone and in Combination With Timolol Ophthalmic Solution, in Subjects With Open Angle Glaucoma or Ocular Hypertension (Angel-J2 Study)Status: Recruiting, Estimated PCD: 2024-01-31
Clinical trial
A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1012600 Ophthalmic Solution 0.002% Compared With Latanoprost 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (Angel-J1 Study)Status: Completed, Estimated PCD: 2023-04-18
Clinical trial
Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males VolunteersStatus: Completed, Estimated PCD: 2023-06-21